• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Study questions success of health intervention currently used in developing countries

Bioengineer by Bioengineer
June 26, 2019
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In the early 20th century, researchers in Massachusetts studied the first community-based health intervention in the world, the Framingham Health and Tuberculosis Demonstration, deeming it highly successful in controlling tuberculosis (TB) and reducing mortality. Now a new study, which used recently digitized data on causes of death during that period, has concluded that the effort was not as successful as initially thought, and suggests that the intervention cannot be cited as evidence for the success of health policies in the era before antibiotics became available. Because the intervention inspired a number of contemporary health demonstrations and projects used in developing countries today, the new study raises serious questions.

The new study, by researchers at Carnegie Mellon University, the University of Southern Denmark, the University of Copenhagen, and the University of Michigan, appears in a working paper of the National Bureau of Economic Research.

“Our findings imply that the original intervention was unsuccessful,” says Karen Clay, professor of economics and public policy at Carnegie Mellon University’s Heinz College, who led the study. “Our results also contribute to the ongoing debate over whether public-health interventions mattered for the decline in mortality from TB prior to modern medicine. And they raise questions about this particular type of intervention–a community-based program that didn’t assign people randomly to treatment options–as a method for evaluating policy interventions.”

In the new study, researchers rigorously analyzed the effects of the first public health demonstration on mortality from TB, total mortality, and infant mortality. In that demonstration, begun in 1917, the National Association for the Study and Prevention of Tuberculosis, funded by Metropolitan Life Insurance Company, chose Framingham, Massachusetts, as a typical American community. Located 32 miles west of Boston, Framingham had an immigrant population of 27% that mirrored the immigrant population of the United States as a whole.

The six-year intervention featured a number of efforts to control TB in the town. A survey of sickness was done, as were studies of sanitary conditions in schools and factories; there was also a tuberculin survey of area cattle. The demonstration also initiated a consultation service; led by a doctor, it helped local physicians diagnose TB and connected patients with doctors and treatment options. In addition, infant welfare clinics helped mothers and babies receive adequate care, informational campaigns provided tips on how to prevent TB, and increased funding boosted health efforts in schools.

In 1923, at the end of the intervention, the association announced that TB and infant mortality had decreased 69% in Framingham; in seven similar communities that did not receive the intervention, TB and infant mortality decreased just 32%, the association said.

In the current study, researchers used newly digitized vital statistics for towns and cities in Massachusetts from 1901 to 1934 to gauge mortality associated with TB and in infants. To evaluate the effect of the original intervention, the researchers constructed a counterfactual city using data from other cities and different statistical methods to determine what would have happened in a city like Framingham if the demonstration had not been carried out there.

In contrast to the positive conclusions of the original study and the subsequent historical narrative, the current study found that the Framingham intervention did not reduce mortality from TB, total mortality, or infant mortality. The intervention did increase the number of TB cases that were discovered.

“The implication of our findings is that the Framingham Demonstration was not as successful as believed and that public health policy was not a decisive factor in the reduction of TB mortality,” Clay says.

###

The research was supported by Carnegie Mellon University and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Summarized from an NBER Working Paper, Controlling Tuberculosis? Evidence from the First Community-Wide Health Experiment by Clay, K (Carnegie Mellon University), Egedesø, PJ (University of Southern Denmark), Hansen, CW (University of Copenhagen), Jensen, PS (University of Southern Denmark), and Calkins, A (University of Michigan). Copyright 2019 by the authors. All rights reserved.

About Carnegie Mellon University’s Heinz College

The Heinz College of Information Systems and Public Policy is home to two internationally recognized graduate-level institutions at Carnegie Mellon University: the School of Information Systems and Management and the School of Public Policy and Management. This unique colocation combined with its expertise in analytics set Heinz College apart in the areas of cybersecurity, health care, the future of work, smart cities, and arts & entertainment. In 2016, INFORMS named Heinz College the number one academic program for Analytics Education. For more information, please visit http://www.heinz.cmu.edu.

Media Contact
Caitlin Kizielewicz
[email protected]

Tags: Death/DyingDemographyDisease in the Developing WorldEpidemiologyImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthMortality/LongevityPublic HealthVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    39 shares
    Share 16 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling EMT’s Role in Colorectal Cancer Spread

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.